Lexicon Pharmaceuticals (LXRX) Revenue (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Revenue of $21.1 million for Q1 2026, up 1572.11% year-over-year from $1.3 million in Q1 2025, and up 284.16% quarter-over-quarter from $5.5 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Revenue (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 16 years of Revenue data on file, last reported at $21.1 million in Q1 2026.
- Revenue for Q1 2026 came in at $21.1 million, up 1572.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.6 million (up 123.12% YoY), and the FY2025 annual result was $49.8 million, up 60.24% from the prior year.
- Revenue advanced to $21.1 million in Q1 2026 per LXRX's latest filing, from $5.5 million in the prior quarter.
- Over five years, Revenue peaked at $28.9 million in Q2 2025 and troughed at $162000.0 in Q3 2023.
- A 4-year average of $8.6 million and a median of $1.7 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue jumped 3366.58% in 2024, then tumbled 79.31% in 2025.
- A 4-year view of Revenue shows it stood at $766000.0 in 2023, then jumped by 3366.58% to $26.6 million in 2024, then plunged by 79.31% to $5.5 million in 2025, then soared by 284.16% to $21.1 million in 2026.
- Business Quant data shows LXRX's Revenue at $21.1 million in Q1 2026, $5.5 million in Q4 2025, and $14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 750.45 Mn | 579.79 Mn | 20.99 Mn | 21.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.10 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 14.18 Mn |
| Jun 30, 2025 | 28.87 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 26.55 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 766,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 317,000.00 |
| Dec 31, 2021 | -284,000.00 |
| Jun 30, 2021 | 234,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | -23.76 Mn |
| Jun 30, 2020 | 25,000.00 |
| Mar 31, 2020 | 8.00 Mn |
| Dec 31, 2019 | 8.73 Mn |
| Sep 30, 2019 | 294.45 Mn |